We are live on
!
Find out more
LCG
Lisanti Capital Growth Portfolio holdings
AUM
$397M
1-Year Est. Return
178.66%
This Fund
S&P 500
This Quarter
Est. Return
-8.6%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$736M
AUM Growth
-$154M
(-17%)
Cap. Flow
-$53.9M
Cap. Flow
% of AUM
-7.32%
Top 10 Holdings %
Top 10 Hldgs %
22.86%
Holding
152
New
40
Increased
35
Reduced
25
Closed
52
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Halozyme
HALO
|
+$15.2M |
| 2 |
Huron Consulting
HURN
|
+$14.2M |
| 3 |
Harmony Biosciences
HRMY
|
+$13.7M |
| 4 |
Applied Industrial Technologies
AIT
|
+$13.1M |
| 5 |
Ollie's Bargain Outlet
OLLI
|
+$11.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MaxLinear
MXL
|
+$18.3M |
| 2 |
Freshpet
FRPT
|
+$13.4M |
| 3 |
Red Rock Resorts
RRR
|
+$12.9M |
| 4 |
Coherent
COHR
|
+$12.7M |
| 5 |
FormFactor
FORM
|
+$12.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.88% |
| 2 | Technology | 23.88% |
| 3 | Industrials | 20.04% |
| 4 | Consumer Staples | 6.39% |
| 5 | Consumer Discretionary | 5.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
DigitalOcean
DOCN
$15B
| $10.2M | 1.38% |
246,530
+44,385
| +22% | +$1.98M |
|
27
FTI Consulting
FCN
$4.34B
| $9.82M | 1.33% |
+54,315
| New | +$8.96M |
|
28
Clean Harbors
CLH
$16.4B
| $9.24M | 1.26% |
105,451
+20,706
| +24% | +$2M |
|
29
Grocery Outlet
GO
$987M
| $9.06M | 1.23% |
+212,500
| New | +$7.76M |
|
30
GFL Environmental
GFL
$15.2B
| $8.66M | 1.18% |
+335,750
| New | +$9.96M |
|
|
INST
31
DELISTED
Instructure Holdings, Inc.
INST
| $8.62M | 1.17% |
379,506
+145,751
| +62% | +$2.75M |
|
32
Evolent Health
EVH
$349M
| $8.58M | 1.17% |
+279,415
| New | +$8.14M |
|
33
Planet Fitness
PLNT
$4.43B
| $8.19M | 1.11% |
120,347
+14,034
| +13% | +$1.04M |
|
|
ONT
34
Onterris Inc
ONT
$827M
| $8.01M | 1.09% |
237,258
+30,968
| +15% | +$1.29M |
|
35
Silicon Laboratories
SLAB
$7.2B
| $7.88M | 1.07% |
+56,160
| New | +$7.86M |
|
|
SLCA
36
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $7.65M | 1.04% |
670,061
+365,701
| +120% | +$6.14M |
|
37
Pacira BioSciences
PCRX
$1.09B
| $7.63M | 1.04% |
130,873
-171,540
| -57% | -$11.2M |
|
|
AYX
38
DELISTED
Alteryx Inc
AYX
| $7.59M | 1.03% |
+156,755
| New | +$9.38M |
|
39
Quanta Services
PWR
$104B
| $7.46M | 1.01% |
59,546
-6,360
| -10% | -$781K |
|
40
Mercury Systems
MRCY
$6.77B
| $7.42M | 1.01% |
+115,425
| New | +$6.89M |
|
41
Patterson-UTI
PTEN
$3.83B
| $7.34M | 1% |
+465,625
| New | +$7.82M |
|
42
iRhythm Holdings
IRTC
$4.18B
| $7.32M | 0.99% |
67,770
-12,150
| -15% | -$1.61M |
|
|
LTHM
43
DELISTED
Livent Corporation
LTHM
| $7.32M | 0.99% |
322,556
-360,690
| -53% | -$9.28M |
|
44
OrthoPediatrics
KIDS
$536M
| $6.93M | 0.94% |
160,623
+31,513
| +24% | +$1.44M |
|
45
Chefs' Warehouse
CHEF
$4.49B
| $6.75M | 0.92% |
173,584
+1,578
| +0.9% | +$55.4K |
|
46
Matador Resources
MTDR
$6.06B
| $6.62M | 0.9% |
142,130
-36,140
| -20% | -$1.96M |
|
|
NARI
47
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $6.54M | 0.89% |
96,190
-2,135
| -2% | -$153K |
|
48
LPL Financial
LPLA
$27.9B
| $6.42M | 0.87% |
+34,830
| New | +$6.61M |
|
|
AXNX
49
DELISTED
Axonics, Inc. Common Stock
AXNX
| $6.24M | 0.85% |
110,042
-20,358
| -16% | -$1.12M |
|
50
Insperity
NSP
$2.02B
| $6.18M | 0.84% |
+61,920
| New | +$6.13M |
|
Similar funds
GF
PIM
EH
TPWA
STT
VC
CF
IVLAV
Lisanti Capital Growth's Q2 2022 Portfolio in Review
As of Q2 2022, Lisanti Capital Growth held 152 positions worth $736M, down 17% from $890M the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Lisanti Capital Growth withdrew a net $53.9M in Q2 2022, closing 52 positions and reducing 25 holdings. Its most notable exit was MaxLinear, an estimated $18.3M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.
Against the trend, Lisanti Capital Growth opened a new position in Halozyme worth $15.4M.
- Lisanti Capital Growth's largest Q2 2022 buy was Halozyme: 350,935 shares worth $15.4M.
- Lisanti Capital Growth added most to GitLab in Q2 2022, an estimated $10.2M increase.
- Lisanti Capital Growth's biggest Q2 2022 reduction was Pacira BioSciences, cutting an estimated $11.2M.
- Lisanti Capital Growth fully exited MaxLinear in Q2 2022, selling an estimated $18.3M.
- Lisanti Capital Growth's ten largest holdings make up 23% of its $736M portfolio in Q2 2022.
- Lisanti Capital Growth opened 40 new positions and closed 52 in Q2 2022.
- Lisanti Capital Growth's portfolio value fell 17% quarter-over-quarter to $736M.
Based on Lisanti Capital Growth's 13F filing for Q2 2022, filed 3 Aug 2022.